triamcinolone acetonide
NDC 45802-817, triamcinolone acetonide, ointment, from Padagis Israel Pharmaceuticals Ltd.
- Product NDC
- 45802-817
- Status
- Listed
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212460
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45802-817 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRIAMCINOLONE ACETONIDE.5 mg/g
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45802-817-01 | 45802081701 | 430 g in 1 JAR (45802-817-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/3cb47c24-b7eb-4709-8a41-cbeceadbc8d9NADAC price for package 45802081701
GET /v1/drugs/nadac/45802081701
Use it
Look up 45802-817 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45802-817 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45802-817. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.